δPKC inhibition or e{open}PKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 4, 2010, Pages 746-756

  Monti, Martina ^a   Donnini, Sandra ^a   Giachetti, Antonio ^a   Mochly Rosen, Daria ^b   Ziche, Marina ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary endothelial cells; Nitric Oxide Synthase; Protein kinase C; Reactive oxygen species

Indexed keywords

CASPASE 3; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; CYCLIC GMP; OXYGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; COW; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; NITRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; ANIMAL; CATTLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYME ACTIVATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CATTLE; CAVEOLIN 1; CELL SURVIVAL; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE NITROGEN SPECIES;

EID: 77649275766     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.11.002     Document Type: Article

References (27)

1. Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 387 12 (2006) 1521-1533
2. Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart 90 5 (2004) 491-493
3. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., and Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5 6 (1992) 834-842
4. Dudzinski D.M., and Michel T. Life history of eNOS: partners and pathways. Cardiovasc. Res. 75 2 (2007) 247-260
5. Mount P.F., Kemp B.E., and Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 42 2 (2007) 271-279
6. Fleming I., Schulz C., Fichtlscherer B., Kemp B.E., Fisslthaler B., and Busse R. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thromb. Haemost. 90 5 (2003) 863-871
7. Bright R., Steinberg G.K., and Mochly-Rosen D. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res. 1144 (2007) 146-155
8. Nakano A., Cohen M.V., and Downey J.M. Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol. Ther. 86 3 (2000) 263-275
9. Inagaki K., Churchill E., and Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc. Res. 70 2 (2006) 222-230
10. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268 5208 (1995) 247-251
11. Souroujon M.C., and Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat. Biotechnol. 16 10 (1998) 919-924
12. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., Cavallaro G., Banci L., Guo Y., Bolli R., Dorn G.W., and Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. U. S. A. 98 20 (2001) 11114-11119
13. Inagaki K., Hahn H.S., Dorn G.W., and Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108 7 (2003) 869-875
14. Ikeno F., Inagaki K., Rezaee M., and Mochly-Rosen D. Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. Cardiovasc. Res. 73 4 (2007) 699-709
15. Schelling M.E., Meininger C.J., Hawker Jr. J.R., and Granger H.J. Venular endothelial cells from bovine heart. Am. J. Physiol. 254 6 Pt 2 (1988) H1211-1217
16. Ziche M., Parenti A., Ledda F., Dell'Era P., Granger H.J., Maggi C.A., and Presta M. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res. 80 6 (1997) 845-852
17. Zielonka J., Hardy M., and Kalyanaraman B. HPLC study of oxidation products of hydroethidine in chemical and biological systems: ramifications in superoxide measurements. Free Radic. Biol. Med. 46 3 (2009) 329-338
18. Donnini S., Solito R., Giachetti A., Granger H.J., Ziche M., and Morbidelli L. Fibroblast growth factor-2 mediates angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. J. Pharmacol. Exp. Ther. 319 2 (2006) 515-522
19. Donnini S., Cantara S., Morbidelli L., Giachetti A., and Ziche M. FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ. 13 7 (2006) 1088-1096
20. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., and Mochly-Rosen D. Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem. Biol. 8 12 (2001) 1123-1129
21. Kraft A.S., and Anderson W.B. Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301 5901 (1983) 621-623
22. Roche M., Rondeau P., Singh N.R., Tarnus E., and Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 582 (2008) 1783-1787
23. Zou M.H., Hou X.Y., Shi C.M., Nagata D., Walsh K., and Cohen R.A. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J. Biol. Chem. 277 36 (2002) 32552-32557
24. Rask-Madsen C., and King G.L. Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28 5 (2008) 919-924
25. Shizukuda Y., Tang S., Yokota R., and Ware J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ. Res. 85 3 (1999) 247-256
26. Sud N., Wedgwood S., and Black S.M. Protein kinase Cdelta regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation. Am. J. Physiol., Lung Cell Mol. Physiol. 294 3 (2008) L582-591
27. Tanaka M., Terry R.D., Mokhtari G.K., Inagaki K., Koyanagi T., Kofidis T., Mochly-Rosen D., and Robbins R.C. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation 110 11 Suppl 1 (2004) II194-II199